Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency.

about

Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency.

Item

http://www.wikidata.org/entity/Q52147611

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Pegvisomant-primed glucagon st ...... ts suspected of GH deficiency.

@en

Pegvisomant-primed glucagon st ...... ts suspected of GH deficiency.

@nl

type

Item

label

Pegvisomant-primed glucagon st ...... ts suspected of GH deficiency.

@en

Pegvisomant-primed glucagon st ...... ts suspected of GH deficiency.

@nl

prefLabel

Pegvisomant-primed glucagon st ...... ts suspected of GH deficiency.

@en

Pegvisomant-primed glucagon st ...... ts suspected of GH deficiency.

@nl

P1476

Pegvisomant-primed glucagon st ...... ts suspected of GH deficiency.

@en

P2093

Jan Frystyk

http://www.w3.org/2001/XMLSchema#string

Kevin C J Yuen

http://www.w3.org/2001/XMLSchema#string

Martin Bidlingmaier

http://www.w3.org/2001/XMLSchema#string

Sharon A Rhoads

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency

Physiology and pathophysiology of growth hormone-binding protein: methodological and clinical aspects

Impact of experimental blockade of peripheral growth hormone (GH) receptors on the kinetics of endogenous and exogenous GH removal in healthy women and men.

A pegylated growth hormone receptor antagonist, pegvisomant, does not enter the brain in humans.

Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency.

Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study.

The growth hormone deficiency syndrome in adults.

Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.

Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinol

Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency?

P2888

s11102-015-0688-8

P304

65-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11102-015-0688-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26496767

http://www.w3.org/2001/XMLSchema#string